PACS Group Stock Jumps as Raised EBITDA Outlook Cuts Through Regulatory Noise
PACS Group shares surged 23% Tuesday after Q1 results beat estimates, with revenue up 11.2% to $1.42 billion and net income rising to $80.7 million. The company raised its 2026 adjusted EBITDA outlook to $605–$625 million and authorized a $250 million buyback. PACS still faces DOJ and SEC investigations and internal-control issues. Over 2.1 million shares traded as the stock hit $41.63 before settling near $39.30.